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Prognostic value of 24-hour ambulatory blood pressure mon-
itoring and of night/day ratio in nondiabetic, cardiovascular
events–free hemodialysis patients.
Background. The use of 24-hour ambulatory blood pressure
monitoring is increasing in end-stage renal disease (ESRD) pa-
tients but the prediction power for cardiovascular complications
of time-averaged ambulatory blood pressure components has
been little investigated in these patients.
Methods. We analyzed the prognostic power of 24-hour am-
bulatory blood pressure monitoring for all-cause and cardio-
vascular mortality in 168 nondiabetic, events-free hemodialysis
patients selected from a total dialysis population of about 450
patients.
Results. During the follow-up period (38 ± 22 months), 48 pa-
tients died, 29 of them of cardiovascular causes. On univariate
Cox regression analyses, the night/day systolic ratio resulted
to be the sole blood pressure indicator to be associated with
all-cause and cardiovascular mortality while left ventricular hy-
pertrophy (LVH) was a strong predictor of these outcomes. In
multivariable Cox models not including LVH, the night/day sys-
tolic ratio maintained an independent prognostic value for in-
cident outcomes. However, when both risk factors, LVH and
night/day systolic ratio, were introduced into Cox models, LVH
was no longer a significant predictor while the night/day systolic
ratio became a predictor of marginal statistical significance.
Conclusion. The night/day ratio emerges as the sole ambu-
latory blood pressure monitoring–derived indicator providing
significant prognostic information in patients with ESRD. How-
ever, this indicator as well as LVH loses substantial prediction
power in statistical models including both risk factors. The re-
sults suggest that the night/day systolic ratio and LVH provide
overlapping prognostic information, a phenomenon in keep-
ing with the hypothesis that they represent a common pathway
leading to adverse outcomes in ESRD.
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The relationship between arterial pressure and cardio-
vascular outcomes is perhaps one of the most intriguing
and controversial issues in renal medicine [1]. While in the
general population without cardiovascular complications
there is a direct, strong relationship between blood pres-
sure and incident cardiovascular events [2–4], in dialysis
patients either no or inverse relationships have been re-
ported in very large dialysis cohorts [5–9]. This apparently
paradoxic phenomenon, which was lucidly described in
a seminal study by Foley et al [10], is currently inter-
preted as an expression of the inverse epidemiology of
this population [11, 12]. However, to date there is no study
directly addressing the hypothesis that hypertension trig-
gers cardiovascular events via left ventricular hyper-
trophy (LVH) [10]. According to this hypothesis, LVH
generated by hypertension causes heart failure which
transforms the blood pressure cardiovascular events re-
lationship from a direct into an inverse one, hypotension
being eventually a marker of pump failure. Testing this
hypothesis would demand enrolment of patients without
cardiovascular complications and without pronounced al-
terations in left ventricular mass at baseline, as well as
precise assessment of the blood pressure burden. Since
LVH is pervasive in the dialysis population (prevalence
rate 80%) selecting hemodialysis patients without LVH
is a costly and lengthy approach posing objective enrol-
ment difficulties. We thought that the problem could be
pragmatically approached by collecting reliable estimates
of blood pressure load (24-hour ambulatory blood pres-
sure monitoring) [13] in a well-selected study population
composed by individuals at low baseline cardiovascular
risk.
With this background in mind, in 1994 we started a
multicenter cohort study investigating the relationship
between 24-hour ambulatory blood pressure monitor-
ing components and cardiovascular outcomes in nondi-
abetic, cardiovascular events–free, hemodialysis patients
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without clinical evidence of heart failure at enrollment.
This is the largest 24-hour ambulatory blood pressure
monitoring study in dialysis patients performed so far
and the sole prospective study investigating the relation-
ship between 24-hour ambulatory blood pressure moni-
toring and mortality and incident cardiovascular events
in a selected cohort composed by low-risk dialysis pa-
tients. To circumvent the confounding effect of baseline
left ventricular mass we modeled the influence of LVH
on survival by multivariate analysis. Of note, this par-
ticular study setting was also ideally suited for testing
whether alterations in circadian blood pressure control
trigger cardiovascular events in this population, a pos-
sibility suggested by small studies in unselected patients
[14, 15] and by some cross-sectional observations [16, 17].
METHODS
Protocol
The protocol was in conformity with the ethical guide-
lines of our institutions and informed consent was ob-
tained from each participant.
Study cohort
Patients were enrolled in three dialysis units (Reggio
Calabria, Firenze, and Perugia). For the selection criteria
adopted for this study, patients had to be nondiabetic and
cardiovascular events–free and without a history or clin-
ical evidence of heart failure. Heart failure was defined
pragmatically as suggested by Foley (i.e., dyspnea in ad-
dition to two of the following conditions, raised jugular
pressure, bibasilar crackles, pulmonary venous hyperten-
sion, or interstitial edema on chest x-ray films, requiring
hospitalization or extra ultrafiltration) [18]. From a whole
dialysis population of about 450 individuals, 168 patients
(85 males and 83 females) met the enrollment criteria.
These patients had been on regular hemodialysis treat-
ment for a median time of 54 months (interquartile range
19 to 76 months).
Patients were being treated three times a week
with standard bicarbonate dialysis (sodium 138 mmol/L,
HCO3 35 mmol/L, potassium 1.5 mmol/L, calcium 1.25
mmol/L, andMg 0.75 mmol/L) by cuprophan or semisyn-
thetic membranes. Dry weight was targeted in each case
to achieve a normotensive edema-free state. The average
urea Kt/V in these patients was 1.21 ± 0.24. Forty patients
were habitual smokers and 89 patients were on treatment
with erythropoietin. Ninety patients were on antihyper-
tensive therapy [49 on monotherapy with angiotensin-
converting enzyme (ACE) inhibitors, calcium channel
blockers, beta-blockers, sympathicolitic agents, diuretics,
and vasodilators and 41 on double (N = 28), triple (N =
11), or quadruple (N = 2) therapy with various combina-
tions of these drugs]. The main demographic and clinical
characteristics of the study population are summarized in
Table 1 (first column).
Follow-up study
After the initial assessment patients were followed up
for an average time of 38 ± 22 months (range 1.7 to 98.5
months). During the follow-up period fatal cardiovascu-
lar events and death were accurately recorded. As a part
of the review process, all available medical information
about each death was collected. This information always
included study and hospitalization records. In the case
of an out-of-hospital death, family members were inter-
viewed by telephone to better ascertain the circumstances
surrounding death.
24-hour ambulatory blood pressure monitoring
Twenty-four–hour ambulatory blood pressure moni-
toring was performed during a nondialysis day by using
two devices conforming to the AAMI recommendations
(Takeda 2420 modification 7) Takeda, Tokyo, Japan)
(Spacelabs 90207) (Redmond, WA, USA). All 24-hour
ambulatory blood pressure monitoring recordings were
carried out every 15 minutes both during the day (07:00
a.m. to 11:00 p.m.) and during the night (11:00 p.m. to
07:00 a.m.). The cuff was placed on the nonfistula arm and
the patients were instructed to maintain their usual level
of activity. Twenty-four–hour ambulatory blood pres-
sure monitoring data were stored on personal comput-
ers. Blood pressure readings were printed out for direct
inspection and edited according to a well-established pro-
tocol [19].
We tested by the Bland-Altman method [20] the repro-
ducibility of the night/day systolic ratio in 19 patients who
underwent 48-hour ambulatory blood pressure monitor-
ing in 2 consecutive days (dialysis interval and dialysis
day).
Predialysis blood pressure
Predialysis blood pressure was calculated as the av-
erage value of 12 recordings (three/week) taken by the
nurses immediately before dialysis during the month pre-
ceding the study [17].
Definitions
As an indicator of night day arterial pressure fall we
considered the night/day systolic ratio (i.e., the ratio of
the average value of systolic pressure during the night
(11:00 p.m. to 7:00 a.m.) and the corresponding average
value of systolic pressure during the day (07:00 a.m. to
11:00 p.m.). We elected to use this ratio than the night-day
blood pressure fall because this ratio is less dependent on
absolute blood pressure values than the night-day blood
pressure fall [21]. Diagnosis of 24-hour ambulatory blood
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Table 1. Main demographic, somatometric, clinical and biochemical characteristics of patients included in the study
Night/day systolic ratio
II tertile
Whole group I tertile (<0.93) (0.94-1.01) III tertile (>1.01) P for trend
Age years 57.2 ± 15.8 55.9 ± 16.2 58.2 ± 15.9 57.4 ± 15.7 0.64
Male gender% 51 49 55 47 0.84
Smokers% 24 27 18 28 0.80
Duration of regular hemodialysis 54 (19–76) 45 (16–73) 55 (28–74) 62 (16–104) 0.59
treatment months
On anti-hypertensive therapy% 54 47 53 60 0.19
24-hour arterial pressure mm Hg
Systolic pressure 141.0 ± 25.4 130.4 ± 24.6 145.9 ± 23.8 144.6 ± 25.5 0.004
Diastolic pressure 78.0 ± 13.1 74.1 ± 11.6 80.6 ± 13.9 78.6 ± 12.9 0.07
Pulse pressure 62.9 ± 19.1 56.4 ± 18.5 65.3 ± 17.8 66.0 ± 19.9 0.01
Diurnal arterial pressure (7.00–22.00)
mm Hg
Systolic pressure 141.7 ± 24.9 134.9 ± 24.8 147.6 ± 23.8 141.1 ± 25.1 0.20
Diastolic pressure 79.3 ± 13.5 76.2 ± 12.2 82.5 ± 13.9 78.4 ± 13.5 0.40
Pulse pressure 62.4 ± 18.9 58.6 ± 18.9 65.1 ± 18.2 62.7 ± 19.5 0.27
Nocturnal arterial pressure (22.00–7.00)
mm Hg
Systolic pressure 138.3 ± 28.6 117.3 ± 23.8 142.7 ± 22.6 151.6 ± 28.3 <0.001
Diastolic pressure 74.9 ± 14.1 67.5 ± 11.6 77.2 ± 14.3 78.9 ± 13.4 <0.001
Pulse pressure 63.4 ± 21.5 49.8 ± 16.9 65.5 ± 18.1 72.7 ± 22.7 <0.001
Predialysis blood pressure
mm Hg
Systolic pressure 145.0 ± 18.2 139.3 ± 21.0 149.0 ± 15.8 145.6 ± 17.1 0.07
Diastolic pressure 80.0 ± 10.2 77.6 ± 11.1 81.8 ± 8.6 80.0 ± 10.8 0.24
Pulse pressure 65.1 ± 13.3 61.7 ± 14.2 67.2 ± 13.2 65.6 ± 12.4 0.13
Hematocrit% 30.8 ± 5.3 31.0 ± 5.4 31.7 ± 5.0 29.6 ± 5.4 0.16
Albumin g/L 41.1 ± 6.4 42.7 ± 3.9 40.3 ± 7.8 40.8 ± 6.1 0.19
Cholesterol mmol/L 4.96 ± 1.42 4.84 ± 1.13 5.01 ± 1.68 5.00 ± 1.33 0.62
Calcium ∗ phosphate mmol2/L2 4.59 ± 1.18 4.35 ± 1.01 4.48 ± 1.27 4.92 ± 1.16 0.01
Kt/V 1.21 ± 0.25 1.18 ± 0.23 1.20 ± 0.26 1.24 ± 0.25 0.25
Left ventricular hypertrophy% 72 63 73 81 0.03
Incident events
Deaths number (%) 48 (29%) 7 (14%) 19 (31%) 22 (39%) 0.006
Cardiovascular deaths number (%) 29 (60% of 2 (4%) 11 (18%) 16 (28%) 0.001
total deaths)
Data are reported as mean ± SD, median and interquartile range or as percent frequency, as appropriate.
pressure monitoring hypertension was done according to
the threshold of 129/79 mm Hg that corresponds to an
office blood pressure of 140/90 mm Hg [22].
Echocardiography
Echocardiography was performed according to a well-
standardized protocol [23]. LVH was defined by a left
ventricular mass index of over 47 g/m2·7 in women or over
50 g/m2·7 in men.
Statistical analysis
Data are reported as mean ± SD, median and in-
terquartile range or as percent frequency, as appropriate
and the comparison among groups were made by P for
trend.
The prognostic value for all-cause and cardiovascular
mortality of 24-hour ambulatory blood pressure moni-
toring and of night/day systolic ratio was analyzed by
univariate and multivariate Cox’s regression analysis.
As potential confounders we considered a set of well-
established risk factors in dialysis patients: age, gender,
smoking, duration of regular hemodialyis treatment, an-
tihypertensive therapy, hematocrit, albumin, cholesterol,
calcium phosphate product, fractional urea clearance
(Kt/V), and LVH. In a first step we identified all covari-
ates that were significantly associated to all-cause and
cardiovascular mortality with P < 0.05 at univariate Cox
regression analysis. After the definition of basic models
of prognostic variables we tested the predictive power
of the night/day systolic ratio in multivariate Cox’s mod-
els, including all univariate predictors of all-cause and
cardiovascular death. Hazard ratios (HR) and their 95%
confidence intervals (CI) were calculated with the use of
the estimated regression coefficients and their standard
errors in the Cox regression analysis.
The usefulness of night/day systolic ratio and LVH to
predict incident all cause and cardiovascular mortality
was also tested by the analysis of receiver operating char-
acteristic (ROC) curves [24]. All calculations were done
using a standard statistical package (SPSS for Windows,
version 9.0.1, 1999).
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Table 2. Causes of death in the study cohort
Number
Cardiovascular
Myocardial infarction 9
Sudden death 7
Stroke 5
Pulmonary embolism 3
Heart failure 2
Mesenteric infarction 2
Arrhythmia 1
Other causes
Sepsis/Infection 5
Neoplasia 5
Gastrointestinal hemorrhage 3
Cachexia 3
Hyperkalemia 1
Multiple myeloma 1
Liver cirrhosis 1
RESULTS
Twenty-four–hour systolic hypertension was more fre-
quent (N = 118) (70%) than diastolic hypertension (N =
74) (44%) and the night/day systolic ratio was≥1 in 59 out
of 168 dialysis patients (i.e., 35%). As shown in Table 1,
both systolic and diastolic blood pressures showed a min-
imal reduction during night-time in comparison to day-
time (−3.4 mm Hg and −4.4 mm Hg, respectively).
Prognostic value of 24-hour ambulatory blood pressure
monitoring and other risk factors: Univariate analyses
During the follow-up period (38 ± 22 months, range
1.7 to 99.0 months), 48 patients died, 29 of them (i.e.,
60% of total deaths) of cardiovascular causes (Table 2).
The prognostic value of blood pressure measurements
for all-cause and cardiovascular mortality was assessed
by dividing patients into three tertiles according to indi-
vidual ambulatory blood pressure components. As shown
in Table 3, on univariate Cox regression analysis, neither
24-hour ambulatory blood pressure nor day or night am-
bulatory blood pressures were significantly associated to
all-cause and cardiovascular mortality. The night/day sys-
tolic ratio was the sole blood pressure indicator to be
associated with all-cause death (Table 3) and the asso-
ciation between this factor and cardiovascular mortality
appeared particularly strong because patients in the third
tertile of night/day systolic ratio had a risk of cardiovascu-
lar death that was 6.89 times higher than those in the first
tertile (Table 3). The strong link between the night/day
systolic ratio and cardiovascular mortality was also fully
evident when the analysis was carried out on continuous
data [HR (1% increase in night/day systolic ratio) 1.05,
95% CI 1.01-1.08, P = 0.008].
Analyses considering blood pressure components as
continuous variables did not materially differ from those
based on blood pressure tertiles. Because night/day sys-
tolic ratio emerged as the sole significant blood pressure–
Table 3. Univariate Cox regression of 24-hour ambulatory blood
pressure monitoring (tertiles) for all-cause and cardiovascular
mortality
HR and 95% CI
All cause mortality (III vs. I tertile) P value
All-cause mortality 24-hour
blood pressure
Systolic pressure 0.92 (0.47-1.81) 0.80
Diastolic pressure 1.05 (0.53-2.09) 0.88
Pulse pressure 1.03 (0.51-2.08) 0.93
Diurnal blood pressure
Systolic pressure 1.00 (0.51-1.94) 0.99
Diastolic pressure 0.77 (0.39-1.56) 0.47
Pulse pressure 1.05 (0.51-2.17) 0.89
Nocturnal blood pressure
Systolic pressure 1.18 (0.58-2.40) 0.64
Diastolic pressure 1.08 (0.55-2.12) 0.83
Pulse pressure 1.54 (0.74-3.19) 0.24
Night/day systolic ratio 2.66 (1.13–6.25) 0.03
Cardiovascular mortality
24-hour blood pressure
Systolic pressure 1.20 (0.47-3.02) 0.71
Diastolic pressure 1.79 (0.66-4.86) 0.25
Pulse pressure 1.50 (0.59-3.80) 0.40
Diurnal blood pressure
Systolic pressure 1.29 (0.55-3.06) 0.56
Diastolic pressure 0.88 (0.31-2.48) 0.80
Pulse pressure 1.37 (0.52-3.57) 0.52
Nocturnal blood pressure
Systolic pressure 2.30 (0.77-6.87) 0.14
Diastolic pressure 1.79 (0.68-4.72) 0.24
Pulse pressure 2.61 (0.99-6.89) 0.06
Night/day systolic ratio 6.89 (1.58-30.10) 0.01
Data are expressed as hazard ratio (95% CI) and P values.
derived marker to be associated with all-cause and car-
diovascular mortality, further data analysis was restricted
only to this parameter. Of note also LVH (all-cause death
HR 4.30, 95% CI 1.70-10.90; cardiovascular death HR
6.81, 95% CI 1.61-28.74, P ≤ 0.009) and smoking (all-
cause death HR 2.62, 95% CI 1.41-4.86; cardiovascular
death HR 4.86, 95% CI 2.29-10.30, P ≤ 0.002) emerged
as strong univariate predictors of all-cause and cardio-
vascular mortality. Age [HR (1-year increase) 1.05, 95%
CI 1.02-1.07, P < 0.001] and serum cholesterol [HR
(1 mmol/L increase) 0.73, 95% CI 0.56-0.95, P = 0.02]
were significantly associated to all-cause mortality while
serum albumin [HR (1 g/L increase) 0.94, 95% CI 0.90-
0.97, P < 0.001] was strongly and inversely associated to
cardiovascular death. There was no center effect both for
all-cause and cardiovascular mortality. Predialysis blood
pressure components (systolic, diastolic, and pulse pres-
sure) failed to predict both all-cause (P ranging from 0.40
to 0.63) and cardiovascular mortality (P ranging from 0.19
to 0.56).
Correlates of night/day systolic ratio
As shown in Table 1, patients in the third tertile
of night/day systolic ratio had higher 24-hour average
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Table 4. Multivariate Cox regression analysis for all-cause and cardiovascular mortality
Model not including left Model including left
ventricular hypertrophy ventricular hypertrophy
Units of increase HR and 95% CI P value HR and 95% CI P value
All-cause mortality
Age 1 year 1.04 (1.02–1.07) 0.001 1.04 (1.01–1.07) 0.01
Smoking 0, no; 1, yes 3.61 (1.88–6.94) <0.001 3.35 (1.73–6.47) <0.001
Cholesterol 1 mmol/L 0.73 (0.56–0.95) 0.02 0.75 (0.57–0.98) 0.04
Night/day ratio
I tertile <0.93 1a 1a
II tertile 0.94–1.01 2.37 (0.98–5.70) 0.05 2.09 (0.85–5.13) 0.11
III tertile >1.01 2.88 (1.21–6.87) 0.02 2.52 (1.03–6.15) 0.04
Left ventricular hypertrophy 0, no; 1, yes 1.81 (0.64–5.09) 0.26
Cardiovascular mortality
Age 1 year 1.03 (0.99–1.07) 0.07 1.02 (0.98–1.06) 0.31
Smoking 0, no; 1, yes 6.90 (3.08–15.43) <0.001 6.37 (2.83–14.33) <0.001
Albumin 1 g/L 0.93 (0.89–0.97) 0.001 0.93 (0.89–0.97) 0.001
Night/day ratio
I tertile <0.93 1a 1a
II tertile 0.94–1.01 3.59 (0.76–16.9) 0.11 2.89 (0.61–13.72) 0.18
III tertile >1.01 5.73 (1.28–25.56) 0.02 4.33 (0.96–19.61) 0.06
Left ventricular hypertrophy 3.56 (0.76–16.66) 0.11
aReference group.
Data are expressed as hazard ratio (HR) and 95% confidence interval (CI).
systolic and pulse pressure and calcium ∗ phosphate prod-
uct and higher prevalence of LVH than patients in the
other two tertiles. Diurnal ambulatory blood pressure val-
ues as well as predialysis blood pressure components did
not differ in the three tertiles of night/day systolic ratio.
However, there was a highly significant, graded increase
in all nocturnal blood pressure components across the
three tertiles.
Prognostic value of night/day systolic ratio and LVH:
Multivariable and ROC curve analyses
In multivariate Cox models, including all univariate
predictors of all-cause and cardiovascular death but LVH,
the night/day systolic ratio maintained an independent
prognostic power for these outcomes (Table 4). How-
ever, when we introduced LVH into the multivariable
models, this risk factor was no longer a significant predic-
tor while the night/day systolic ratio became a predictor
of marginal statistical significance (Table 4). When ana-
lyzed with the ROC curve approach, the night/day sys-
tolic ratio and LVH had very close predictive power and
the gain in prediction power which could be obtained
by jointly considering the two risk factors was of modest
degree (+5% both for all-cause and cardiovascular mor-
tality) (see Fig. 1). Collectively, these results suggest that
the night/day systolic ratio and LVH provide overlapping
prognostic information, a phenomenon suggesting that
they, at least in part, represent a common pathway lead-
ing to adverse outcomes. In keeping with this hypothesis
there was a graded relationship between the prevalence
of LVH and night/day systolic ratio and predialysis sys-
tolic blood pressure, an association also present with day
and night systolic blood pressures (Fig. 2).
Night/day systolic ratio reproducibility
The reproducibility of the night/day systolic ratio was
tested in patients who underwent 48-hour ambulatory
blood pressure monitoring in 2 consecutive days (dialysis
interval and dialysis day). In these patients the night/day
systolic ratio resulted to be a satisfactorily reproducible
measurement because no point exceeded the two SD in
the Bland-Altman graph (Fig. 3).
DISCUSSION
In a low-risk cohort of 168 nondiabetic hemodialysis
patients without heart failure and without background
cardiovascular complications the night/day systolic ratio
emerged as the sole blood pressure indicator to be as-
sociated to all-cause and cardiovascular mortality and
its prognostic value for these outcomes was largely de-
pendent on LVH. Furthermore, no diurnal or nocturnal
24-hour ambulatory blood pressure components as well
as predialysis blood pressure resulted to be significantly
related to all-cause and cardiovascular mortality.
Study cohort
Due to the high frequency of diabetes, heart failure, and
background cardiovascular complications (the exclusion
criteria of this study) we could select just about one third
of patients of a large dialysis population (N = 450). Such
an exclusion process is fundamental for minimizing the
effect of the “inverse epidemiology” phenomenon (i.e.,
the phenomenon whereby advanced cardiovascular dis-
ease and heart failure lead to hypotension and death).
The selection process applied to our population was well
reflected in the relatively low mortality rate of our cohort
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Fig. 1. Receiver operating characteristic (ROC) curves analysis of the night/day systolic ratio and left ventricular hypertrophy (LVH) for all-cause
and cardiovascular mortality.
(9%/year) which was by 78% lower than that the average
figure in European countries (16%/year) [25].
24-hour ambulatory blood pressure monitoring and
cardiovascular risk in dialysis patients
Twenty-four–hour ambulatory blood pressure moni-
toring is widely used in clinical practice and it is formally
incorporated in recent guidelines for the diagnostic, prog-
nostic, and therapeutic evaluation of hypertension [26].
This technique provides not only average estimates of
24-hour blood pressure components but also estimates
of blood pressure load during day and night as well as
blood pressure variability [27]. The application of 24-hour
ambulatory blood pressure monitoring in patients with
end-stage renal disease (ESRD) may be of particular in-
terest because these patients frequently show an altered
circadian blood pressure profile characterized by a re-
duced or abolished blood pressure fall during the night
[28–30]. In our study the vast majority of dialysis patients
displayed arterial hypertension as defined on the basis of
specific 24-hour ambulatory blood pressure monitoring
guidelines [22], a finding further again emphasizing the
pervasive nature of this complication in ESRD. However,
we found no significant association between 24-hour sys-
tolic, diastolic, and pulse pressure with incident all-cause
and cardiovascular mortality. Furthermore, none of pre-
dialysis blood pressure components were significantly as-
sociated with outcomes. The fact that predialysis blood
pressure is not associated with death and cardiovascular
events goes along with the observation that none of the
diurnal 24-hour ambulatory blood pressure monitoring
components (i.e., measurements made in a time frame en-
compassing predialysis measurements) predicts adverse
outcomes. The lack of a significant association between
24-hour ambulatory blood pressure monitoring and inci-
dent mortality in our cohort is in apparent contrast with
the results emerged in a study by Liu et al [14] where
24-hour ambulatory blood pressure monitoring were in-
versely associated to incident cardiovascular outcomes.
Yet, this relatively small study (80 ESRD patients) in-
cluded a substantial proportion (39%) of diabetics. The
propensity of diabetic uremics for left ventricular dis-
orders and autonomic neuropathy is a most likely con-
founder for the association between blood pressure and
incident cardiovascular events. In the study by Amar et al
[15] in 57 dialysis patients both 24-hour systolic and dias-
tolic blood pressure failed to significantly predict cardio-
vascular mortality after data adjustment for age, gender,
and background cardiovascular complications but again
this study included diabetics (14%) and patients with pre-
vious cardiovascular complications (34%).
Night/day systolic ratio and cardiovascular risk
In the present study, we used the night/day systolic ra-
tio, as an indicator of the night day blood pressure change,
because it is well demonstrated that it is the best indicator
of the dipping status [21]. We found that nocturnal hyper-
tension (night/day systolic ratio >1) was very common in
hemodialysis patients (35%). Quite remarkably this ratio
resulted to be the sole blood pressure–derived marker to
be associated to all-cause and cardiovascular mortality.
The night/day blood pressure fall and the average sys-
tolic pressure during night predicted cardiovascular out-
comes also in Liu et al [14] and Amar et al [15] studies.
Thus, notwithstanding differences in patient characteris-
tics and in indicators of nocturnal blood pressure changes,
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Fig. 2. Relationship between night/day systolic ratio, predialysis systolic pressure, day and night systolic blood pressures with the prevalence rate
of left ventricular hypertrophy (LVH). Patients are divided into three tertiles on the basis of individual values of each blood pressure component.
Comparisons among groups were made by P for trend.
the lack of blood pressure fall during night appears a co-
herent marker of high cardiovascular risk. In this regard
our analysis which modeled the incidence of cardiovascu-
lar events on the basis of LVH gives an insight into the se-
quence of events leading to these outcomes. Indeed, while
once again we confirmed that LVH is a strong predic-
tor of all-cause and cardiovascular mortality, the simul-
taneous inclusion of this risk factor and of the night/day
systolic ratio into the same statistical models produces a
substantial loss of predictive power of LVH and a less
pronounced, yet important, loss of predictive power of
the night/day systolic ratio. This statistical phenomenon
suggests that the inverted arterial pressure pattern dur-
ing night-time and LVH are in part in the same causal
pathway leading to death and cardiovascular sequelae.
The interpretative clue provided by statistical modeling
is also fully coherent with the strong, direct relationship
between the night/day ratio and left ventricular mass in-
dex. Like in previous studies we found that LVH was
strongly associated not only with the night/day systolic ra-
tio but also with other 24-hour ambulatory blood pressure
components and with predialysis systolic pressure, all
Tripepi et al: Prognostic value of 24-hour ambulatory blood pressure monitoring in ESRD 1301
0.25
0.20
0.15
0.10
D
iff
e
re
n
ce
 in
 th
e 
ni
gh
t/d
ay
 s
ys
to
lic
 
ra
tio
 o
f t
he
 fi
rs
t a
nd
 th
e 
se
co
nd
 d
ay
s
0.05
0.00
0.7 0.8 0.9 1.0
Average night/day systolic ratios
1.1 1.2
−0.05
−0.10
−0.15
−0.20
−0.209
−1.96 SD
0.178
+1.96 SD
−0.016
Mean
−0.25
Fig. 3. Bland-Altman analysis of the repro-
ducibility of night/day systolic ratio in a sub-
group of 19 hemodialysis patients who un-
derwent 48-hour ambulatory blood pressure
monitoring during 2 consecutive days.
associations supporting the contention that arterial hy-
pertension leads to LVH and that in turn LVH is a major
pathway mediating the adverse effects of hypertension.
However plausible this interpretation, the question re-
mains why the night/day ratio, but not other arterial pres-
sure components, maintains an independent (although
weak) relationship with cardiovascular death. We have
no direct elements to explain this finding. However,
it is likely that the night/day ratio (or the night/day
blood pressure difference) is an indicator conveying in-
formation beyond arterial pressure. Indeed the night/day
systolic ratio but not other blood pressure component
is associated with nocturnal hypoxemia [30] and sym-
pathetic overactivity [14] which may per se be con-
ducive to cardiovascular death by LVH-dependent and
-independent mechanism. In our study, the largest per-
formed so far and the sole based on a low-risk cohort,
the night/day ratio emerges as the sole blood pressure–
derived indicator providing prognostic information in
ESRD patients. It is interesting to note that the night/day
systolic ratio retained a residual predictive power for
all cause and cardiovascular death in statistical mod-
els, including also LVH and that ROC curve analysis,
showed that the prediction power of this ratio is not
inferior to that LVH which is currently considered the
strongest predictor of cardiovascular complications. This
observation suggests that the night day ratio can be used
for risk stratification in ESRD patients. ESRD patients
with a high night/day systolic ratio should be consid-
ered high-risk patients requiring close clinical supervision
and intensive treatment of risk factors for cardiovascular
disease.
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